Home / Denmark / Novozymes A/S
Novozymes A/S
Short position disclosed on March 31, 2026.
1.00% of the capital sold short
1 disclosing funds
222 disclosures on record
DK0060336014 ISIN code
Evolution of the disclosed total
0%0.25%0.5%0.75%1%
Oct 2025Jan 2026Apr 2026Jul 2026
November 1, 2012 today
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| AQR Capital Management, LLC | 1.00% | new | March 31, 2026 |
On the other side: the funds that hold Novozymes A/S Titelia
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| March 3, 2017 | AQR Capital Management, LLC | 1.00% | March 3, 2017 |
| February 23, 2017 | Marshall Wace LLP | 0.60% | February 23, 2017 |
| February 23, 2017 | Citadel Europe LLP | 0.48% | February 23, 2017 |
| February 17, 2017 | Marshall Wace LLP | 0.52% | February 17, 2017 |
| February 13, 2017 | AQR Capital Management, LLC | 0.90% | February 13, 2017 |
| February 1, 2017 | AQR Capital Management, LLC | 0.80% | February 1, 2017 |
| January 20, 2017 | Citadel Europe LLP | 0.50% | January 20, 2017 |
| January 12, 2017 | AQR Capital Management, LLC | 0.70% | January 12, 2017 |
| January 6, 2017 | Citadel Europe LLP | 0.49% | January 6, 2017 |
| December 13, 2016 | AQR Capital Management, LLC | 0.60% | December 13, 2016 |
| November 13, 2016 | Citadel Europe LLP | 0.50% | November 13, 2016 |
| November 11, 2016 | AQR Capital Management, LLC | 0.50% | November 11, 2016 |
| June 18, 2014 | AQR Capital Management, LLC | 0.41% | June 18, 2014 |
| August 15, 2013 | AKO Capital LLP | 0.45% | August 15, 2013 |
| August 14, 2013 | AKO Capital LLP | 0.55% | August 14, 2013 |
| August 9, 2013 | AKO Capital LLP | 0.69% | August 9, 2013 |
| July 15, 2013 | AKO Capital LLP | 0.70% | July 15, 2013 |
| July 11, 2013 | AKO Capital LLP | 0.64% | July 11, 2013 |
| July 9, 2013 | AKO Capital LLP | 0.52% | July 9, 2013 |
| June 19, 2013 | AQR Capital Management, LLC | 0.59% | June 19, 2013 |
| November 12, 2012 | AQR Capital Management, LLC | 0.52% | November 12, 2012 |
| November 1, 2012 | AQR Capital Management, LLC | 0.60% | November 1, 2012 |
Other companies sold short in Denmark
- Zealand Pharma A/S 6.75% of the capital sold short
- GN Store Nord A/S 4.81% of the capital sold short
- Ambu A/S 4.00% of the capital sold short
- Pandora A/S 2.25% of the capital sold short
- Carlsberg A/S 1.90% of the capital sold short
- Demant A/S 1.89% of the capital sold short
- Netcompany Group A/S 1.58% of the capital sold short
- Aquaporin A/S 1.51% of the capital sold short
- Matas A/S 1.28% of the capital sold short
- Noble Corporation Plc 1.17% of the capital sold short
- ChemoMetec A/S 0.92% of the capital sold short
- Coloplast A/S 0.79% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Novozymes A/S, source Finanstilsynet, data as at March 31, 2026, https://www.quivad.com/action/novozymes-a-s?page=5